DEADLINE ALERT for IOVA, DNUT, and MSTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected].
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA )
Class Period: May 9, 2024 – May 8, 2025
Lead Plaintiff Deadline: July 14, 2025
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) new Authorized Treatment Centers were experiencing longer timelines to begin treating patients with Amtagvi; (2) the Company's sales team and new ATCs were ineffective in patient identification and patient selection for Amtagvi, leading to higher patient drop-offs; (3) the foregoing dynamics led to higher costs and lower revenue because ATCs could not keep pace with manufactured product; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you are an Iovance shareholder who suffered a loss, click here to participate.
Krispy Kreme, Inc. (NASDAQ: DNUT )
Class Period: February 25, 2025 – May 7, 2025
Lead Plaintiff Deadline: May 13, 2025
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that demand for Krispy Kreme products declined materially at McDonald's locations after the initial marketing launch; (2) that demand at McDonald's locations was a driver of declining average sales per door per week; (3) that the partnership with McDonald's was not profitable; (4) that the foregoing posed a substantial risk to maintaining the partnership with McDonald's; (5) that, as a result, the Company would pause expansion into new McDonald's locations; and (6) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you are a Krispy Kreme shareholder who suffered a loss, click here to participate.
MicroStrategy Incorporated d/b/a Strategy (NASDAQ: MSTR )
Class Period: April 30, 2024 – April 4, 2025
Lead Plaintiff Deadline: July 15, 2025
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the anticipated profitability of the Company's bitcoin-focused investment strategy and treasury operations was overstated; (2) the various risks associated with bitcoin's volatility and the magnitude of losses Strategy could recognize on the value of its digital assets following its adoption of ASU 2023-08 were understated; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you are a MicroStrategy shareholder who suffered a loss, click here to participate.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
[email protected]
www.frankcruzlaw.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
EliseAI raises $250 million in a16z-led round to expand in healthcare
By Krystal Hu (Reuters) -Enterprise software maker EliseAI has raised $250 million in a Series E funding round to expand its automation tools for the healthcare and housing industries, the company told Reuters. The latest funding values the company at over $2.2 billion, doubling its valuation from about a year ago. Venture capital firm Andreessen Horowitz led the round, with participation from Bessemer Venture Partners and existing investors such as Sapphire Ventures. Shop Top Mortgage Rates Personalized rates in minutes A quicker path to financial freedom Your Path to Homeownership The New York-based company, which builds AI to automate customer service and operations, said it surpassed $100 million in annual recurring revenue (ARR) earlier this year. The fresh capital will be used to fuel product innovation and double its roughly 300-person team over the next year, its CEO Minna Song told Reuters in an interview, with hiring plans across offices in New York, San Francisco, Boston and Chicago. The funding highlights investor appetite for so-called vertical AI companies that build deeply integrated, industry-specific solutions rather than general-purpose models. For EliseAI, the capital provides the firepower to deepen its hold on the real estate market and scale its newer healthcare division, tackling costly administrative tasks in two of the economy's largest and most complex sectors. "We've seen a fundamental shift in the market, from talking about AI to using it to solve really costly problems," Song said in an interview. "The demand from our customers was really strong, and so we decided that now is the time to invest in scaling." EliseAI's platform is able to automate the entire resolution process by focusing on specific industries, said Alex Immerman, partner at Andreessen Horowitz. "A vertical AI like ours will go really, really deep and will take that customer request and then handle every step that's required to resolve it," he said, including coordinating with vendors, scheduling, and ensuring compliance. The company started by targeting the housing industry in 2017, and expanded its applications to healthcare since 2022, an industry it said is burdened by similar communication friction and manual processes. With generative AI technology bursting onto the scene, its software can handle more complicated customer inquiries and workflows by integrating with models like the ones from OpenAI. It serves Zillow Group and other rental managers, and touts its technology is currently used in one in eight apartments in the U.S. In healthcare, the company has been focusing on outpatient specialties, including dermatology and women's health, integrating with electronic health record systems to automate administrative work. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 minutes ago
- Yahoo
US tech stocks hit by concerns over future of AI boom
US tech stocks sold off as warnings that the hype surrounding artificial intelligence could be overdone hit some of the year's Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 minutes ago
- Yahoo
The Hanover Insurance Group, Inc. Announces Pricing of $500 Million Senior Notes Offering
WORCESTER, Mass., Aug. 19, 2025 /PRNewswire/ -- The Hanover Insurance Group, Inc. (NYSE: THG) today announced it has priced a registered offering of $500 million aggregate principal amount of senior, unsecured 5.50% notes due September 1, 2035 (the "Notes"). The company plans to use the net proceeds from the issuance of the Notes to repay its outstanding 7.625% Senior Notes due October 2025, repay or redeem its outstanding 4.500% Senior Notes due April 2026 (collectively, the "Debentures") and for general corporate purposes. The company anticipates the debt offering will close on or around August 21, 2025, subject to customary closing conditions. Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC are acting as the joint book-running managers for the offering. Nothing herein shall constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification under the securities laws of any such state or jurisdiction. The offering is being made pursuant to an effective shelf registration filed with the Securities and Exchange Commission ("SEC") on August 18, 2025. A prospectus and prospectus supplement related to this offering have been filed with the SEC. This press release does not constitute a notice of redemption with respect to, or any offer to purchase, the Debentures. Any such notice will be given to holders of the Debentures in a manner prescribed in the indenture governing the Debentures. Copies of the prospectus and related prospectus supplement may be obtained at no cost by visiting the SEC website at Alternatively, copies or information concerning this offering may be obtained by contacting the joint book-running managers: Goldman Sachs & Co. LLC at +1 (800) 828-3182, J.P. Morgan Securities LLC at +1 (212) 834-4533, or Morgan Stanley & Co. LLC at +1 (866) 718-1649. About The Hanover The Hanover Insurance Group, Inc. is the holding company for several property and casualty insurance companies, which together constitute one of the largest insurance businesses in the United States. The company provides exceptional insurance solutions through a select group of independent agents and brokers. Together with its agent partners, The Hanover offers standard and specialized insurance protection for small and mid-sized businesses, as well as for homes, automobiles, and other personal items. Forward-Looking Statements This news release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Those forward-looking statements are subject to various risks and uncertainties and include all statements that are not historical statements of fact and those regarding our intent, belief or expectations with respect to future events and financial performance and the debt offering, including the expected closing of the debt offering and the use of proceeds from the debt offering. The company cautions investors that any such forward-looking statements are not guarantees of future performance, and actual results could differ materially. Investors are directed to consider the risks and uncertainties in the company's business that may affect future performance and that are discussed in readily available documents, including those risks which are discussed in the company's annual report and other documents filed by the company with the SEC. Contacts: Investors: Media:Oksana Lukasheva Emily P. Trevallion(508) 525-6081 (508) 855-3263Email: olukasheva@ Email: etrevallion@ View original content to download multimedia: SOURCE The Hanover Insurance Group, Inc.
